2.710EUR+0.37%Mkt Cap: 220.63M EURP/E: 54.20Last update: 2026-06-01
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap220.63M EUR
Enterprise Value303.80M EUR
Revenue (TTM)335.01M EUR
Gross Profit195.85M EUR
Net Income (TTM)5.02M EUR
Revenue/Share4.115 EUR
Last Price2.710 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.4K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0165359029
Valuation
P/E (Trailing)54.20
P/E (Forward)22.50
PEG0.34
EV/EBITDA13.36
EV/Revenue0.91
P/S0.66
P/B0.99
EPS (TTM)0.05
EPS (Forward)0.12
52W Range
2.32036% of range3.400
52W High3.400 EUR
52W Low2.320 EUR
Profitability
Gross Margin59.15%
Oper. Margin4.03%
EBITDA Margin6.79%
Profit Margin1.52%
ROE2.30%
ROA1.27%
Growth
Revenue Growth-1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.51M EUR
CapEx (TTM)18.30M EUR
FCF Margin—
FCF Yield—
Net Debt81.69M EUR
Net Debt/EBITDA3.59
Balance Sheet
Debt/Equity0.42
Current Ratio1.55
Quick Ratio0.87
Book Value/Sh2.718 EUR
Cash/Share0.2650 EUR
Dividends
Fwd Div Rate0.0200 EUR
Trail. Div Rate0.0000 EUR
Div. Yield0.89%
5Y Avg Yield1.51%
Payout Ratio94.59%
Ex-Div DateMay 21, 2026
Pay Date—
Splits
Last Split1:20
Split DateSep 22, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.81.41M
Float21.47M
Insiders79.09%
Institutions7.07%
Technical
SMA 502.641 (+2.6%)
SMA 2002.735 (-0.9%)
Beta0.95
S&P 52W Chg27.94%
Avg Vol (30d)12.64K
Avg Vol (10d)7.14K
Technical Indicators
RSI (14)48.5
MACD0.0130
MACD Signal0.0250
MACD Hist.-0.0120
BB Upper2.818 EUR
BB Middle2.743 EUR
BB Lower2.667 EUR
BB Width5.48%
ATR (14)0.0542 EUR
Vol Ratio (20d)0.56x